Page last updated: 2024-10-24

negative regulation of neuronal action potential

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the frequency, rate or extent of neuronal action potential. [GO_REF:0000058, GOC:TermGenie, PMID:25126967]

Negative regulation of neuronal action potential is a crucial process for controlling the flow of information within the nervous system. It involves a complex interplay of mechanisms that act to decrease the likelihood or intensity of action potentials, ensuring precise and controlled neuronal communication. Here's a detailed description of the process:

1. **Hyperpolarization:** This involves increasing the membrane potential of the neuron, making it more negative than its resting potential. Hyperpolarization reduces the likelihood of an action potential occurring by increasing the threshold that needs to be reached for depolarization. This can be achieved through:
* **Increased potassium permeability:** Opening of potassium channels allows potassium ions to flow out of the neuron, making the inside more negative.
* **Decreased sodium permeability:** Closing of sodium channels reduces the influx of positive sodium ions, further contributing to hyperpolarization.
* **Activation of hyperpolarizing neurotransmitters:** Some neurotransmitters, like GABA and glycine, bind to receptors on the postsynaptic neuron, leading to the opening of chloride channels and influx of negative chloride ions, causing hyperpolarization.

2. **Inhibition of Sodium Channels:** Action potentials rely on the rapid influx of sodium ions through voltage-gated sodium channels. Inhibiting these channels directly prevents the rapid depolarization necessary for an action potential to occur. This inhibition can be achieved through:
* **Inactivation of sodium channels:** After a period of sustained depolarization, sodium channels undergo a temporary inactivation, preventing further sodium influx.
* **Blockage of sodium channels:** Certain toxins and drugs, like tetrodotoxin, can directly bind to and block sodium channels, inhibiting action potential generation.

3. **Activation of Potassium Channels:** Potassium channels play a key role in repolarizing the membrane after an action potential. By increasing potassium permeability, these channels enhance the outward flow of potassium ions, restoring the negative membrane potential. This repolarization phase makes the neuron less susceptible to further excitation.

4. **Regulation of Calcium Influx:** Calcium ions play a critical role in synaptic transmission and neurotransmitter release. However, excessive calcium influx can disrupt neuronal function. Negative regulation of neuronal action potentials often involves mechanisms that reduce calcium influx, such as:
* **Inhibition of voltage-gated calcium channels:** Some neurotransmitters, like GABA, can activate receptors that suppress calcium influx through voltage-gated calcium channels, thereby reducing neurotransmitter release.
* **Activation of calcium-activated potassium channels:** Increased intracellular calcium can activate potassium channels, leading to hyperpolarization and reduction in neuronal excitability.

5. **Presynaptic Inhibition:** This involves reducing the release of excitatory neurotransmitters from the presynaptic neuron, thereby decreasing the likelihood of generating an action potential in the postsynaptic neuron. This can be achieved by:
* **Activation of inhibitory interneurons:** These neurons release inhibitory neurotransmitters that suppress the release of excitatory neurotransmitters from the presynaptic neuron.
* **Modulation of presynaptic receptors:** Some neurotransmitters can bind to receptors on the presynaptic terminal, influencing the release of excitatory neurotransmitters.

6. **Feedback Inhibition:** This mechanism involves the postsynaptic neuron providing feedback to the presynaptic neuron, reducing its activity. This feedback can be mediated by:
* **Axon collateral inhibition:** Axons of some neurons can branch back and synapse on their own dendrites or soma, providing inhibitory feedback.
* **Retrograde signaling:** The postsynaptic neuron can release retrograde messengers that travel back to the presynaptic neuron, modulating its activity.

In summary, negative regulation of neuronal action potentials is a complex and multi-faceted process that plays a crucial role in fine-tuning neuronal communication. These mechanisms ensure that neuronal activity is controlled, preventing uncontrolled firing and maintaining the integrity of information transmission within the nervous system.'
"

Proteins (1)

ProteinDefinitionTaxonomy
G-protein coupled receptor 35A G-protein coupled receptor 35 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9HC97]Homo sapiens (human)

Compounds (28)

CompoundDefinitionClassesRoles
pqq cofactorPQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.

pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
orthoquinones;
pyrroloquinoline cofactor;
tricarboxylic acid
anti-inflammatory agent;
antioxidant;
cofactor;
water-soluble vitamin (role)
amlexanoxamlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.

amlexanox: SRA-A antagonist;structure given in first source
monocarboxylic acid;
pyridochromene
anti-allergic agent;
anti-ulcer drug;
non-steroidal anti-inflammatory drug
cromolyncromoglycic acid : A dicarboxylic acid that is the bis-chromone derivative of glycerol. It is effective as a mast cell stabilizer.chromones;
dicarboxylic acid
anti-asthmatic drug;
calcium channel blocker
furosemidefurosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.

Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
chlorobenzoic acid;
furans;
sulfonamide
environmental contaminant;
loop diuretic;
xenobiotic
kynurenic acidkynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
monohydroxyquinoline;
quinolinemonocarboxylic acid
G-protein-coupled receptor agonist;
human metabolite;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist;
Saccharomyces cerevisiae metabolite
lapachollapachol : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone substituted by hydroxy and 3-methylbut-2-en-1-yl groups at positions 2 and 3, respectively. It is a natural compound that exhibits antibacterial and anticancer properties, first isolated in 1882 from the bark of Tabebuia avellanedae.
niflumic acidNiflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.aromatic carboxylic acid;
pyridines
pamoic acidpamoic acid: RN given refers to parent cpd; structuredicarboxylic acid
coumarin-3-carboxylic acidcoumarin-3-carboxylic acid: structure given in first sourcecoumarins
cromolyn sodiumCromolyn Sodium: A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.

disodium cromoglycate : An organic sodium salt that is the disodium salt of cromoglycic acid.
organic sodium saltanti-asthmatic drug;
drug allergen
doxantrazoledoxantrazole: structure
lodoxamideorganonitrogen compound;
organooxygen compound
bufrolinbufrolin: inhibits the release of histamine; proposed for treatment of hay fever, asthma and skin allergies; minor descriptor (79-86); on line & INDEX MEDICUS search PHENANTHROLINES (79-86); RN given refers to parent cpd
lobaric acidlobaric acid: inhibits formation of leukotrienes C4, D4, and E4; also reduces muscle contraction; structure in first sourcecarbonyl compound
firefly luciferinFirefly Luciferin: A benzothaizole which is oxidized by LUCIFERASES, FIREFLY to cause emission of light (LUMINESCENCE).

Photinus luciferin : A 1,3-thiazolemonocarboxylic acid consisting of 3,5-dihydrothiophene-4-carboxylic acid having a 6-hydroxybenzothiazol-2-yl group at the 2-position.
1,3-thiazolemonocarboxylic acid;
benzothiazoles;
imidothioate
luciferin
5,6-dihydroxy-2-indolylcarboxylic acid5,6-dihydroxyindole-2-carboxylic acid : A dihydroxyindole that is indole-2-carboxylic acid substituted by hydroxy groups at positions 5 and 6.dihydroxyindolemouse metabolite
Thieno[3,2-b]thiophene-2-carboxylic acidthienothiophene
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
luteolin3'-hydroxyflavonoid;
tetrahydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
baicaleintrihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
morinmorin : A pentahydroxyflavone that is 7-hydroxyflavonol bearing three additional hydroxy substituents at positions 2' 4' and 5.

morin: a light yellowish pigment found in the wood of old fustic (Chlorophora tinctoria)
7-hydroxyflavonol;
pentahydroxyflavone
angiogenesis modulating agent;
anti-inflammatory agent;
antibacterial agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
hepatoprotective agent;
metabolite;
neuroprotective agent
myricetin7-hydroxyflavonol;
hexahydroxyflavone
antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
ellagic acidcatechols;
cyclic ketone;
lactone;
organic heterotetracyclic compound;
polyphenol
antioxidant;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor;
EC 2.4.1.1 (glycogen phosphorylase) inhibitor;
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor;
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor;
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
food additive;
fungal metabolite;
geroprotector;
plant metabolite;
skin lightening agent
alpha-cyano-4-hydroxycinnamic acidalpha-cyano-4-hydroxycinnamic acid : A monohydroxycinnamic acid that is 4-hydroxycinnamic acid in which the hydrogen alpha- to the carboxy group is replaced by a cyano group. It is used as a matrix in matrix-assisted laser desorption/ionization (MALDI) mass spectrometry for the analysis of peptides and oligonucleotides.monohydroxycinnamic acid;
nitrile;
phenols
MALDI matrix material
cid-2745687
dicumarolDicumarol: An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.hydroxycoumarinanticoagulant;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
Hsp90 inhibitor;
vitamin K antagonist
zaprinastzaprinast: anaphylaxis inhibitor; structuretriazolopyrimidines
hemateinhematein : An organic heterotetracyclic compound that is -6a,7-dihydrobenzo[b]indeno[1,2-d]pyran-9-one carrying four hydroxy substituents at positions 3, 4, 6a and 10.

hematein: structure